SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-18-041929
Filing Date
2018-02-13
Accepted
2018-02-13 12:56:19
Documents
1
Group Members
CALEB WINDEREXCEL VENTURES II GP, LLCFREDERICK R. BLUMEJUAN ENRIQUEZSTEVEN R. GULLANS

Document Format Files

Seq Description Document Type Size
1 SC 13G d534455dsc13g.htm SC 13G 124021
  Complete submission text file 0001193125-18-041929.txt   125799
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Subject) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81377 | Film No.: 18601449
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON STREET, PRUDENTIAL TOWER BOSTON MA 02199
Business Address 800 BOYLSTON STREET, PRUDENTIAL TOWER BOSTON MA 02199 (617) 450-9800
Excel Venture Fund II, L.P. (Filed by) CIK: 0001538240 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G